Sector: Health & pharmaceuticals

Penalty units set to increase from $180 to $210 from 1 July 2017...

Read More →

In what might be one of the last cases prosecuted under the current version of the ‘misuse of market power’ prohibition in the Competition and Consumer Act 2010 (CCA), the ACCC has commenced proceedings against...

Read More →

No major surgery to the ACL – but rehab likely...

Read More →

Who’s the biggest loser?

May 19, 2016 | 0 Comments

The Federal Court has imposed a penalty of $3.55M against SensaSlim and $660,000 against Peter Foster for engaging in misleading and deceptive conduct and making false representations...

Read More →

ACCC’s big week of penalties

May 7, 2016 | 0 Comments

The past week has seen the Federal Court of Australia hand down pecuniary penalties in five different matters – bringing a total of $38 million for the ACCC. These penalties were ordered against a backdrop...

Read More →

What the effects test means for business

March 17, 2016 | 0 Comments

Government proposal to amend misuse of market power provision in Australia has potential to heighten uncertainty...

Read More →

Lights out for Lumosity misrepresentations in US

February 5, 2016 | 0 Comments

Penalty or compensation, and how much is enough for a regulatory settlement?...

Read More →

What a year InCompetition!

December 24, 2015 | 1 Comments

InCompetition looks back at some of the key events in competition law from 2015 and wishes readers a happy festive season...

Read More →

The Federal Court has found that Reckitt Benckiser engaged in misleading and deceptive conduct in the packaging and online information about a range of Nurofen products....

Read More →

Choose your own section 46 adventure

December 11, 2015 | 0 Comments

Government opens consultation on section 46 reform...

Read More →